References
- Bray, F.; Ferlay, J.; Soerjomataram, I.; Siegel, R. L.; Torre, L. A.; Jemal, A. Global Cancer Statistics 2018: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries. CA Cancer J. Clin. 2018, 68(6), 103–117. The online GLOBOCAN 2018 database is accessible at http://gco.iarc.fr/, as part of IARC’s Global Cancer Observatory
- Zeeneldin, A. A.; Ramadan, H.; El Gammal, M. M.; Saber, M. M.; Elgamal, D.; Sherisher, M. A. Gastric Carcinoma at Tanta Cancer Center: A Comparative Retrospective Clinico-pathological Study of the Elderly versus the Non-elderly. J. Egypt. National Cancer Inst. 2014, 26, 127–137. DOI: https://doi.org/10.1016/j.jnci.2014.04.002.
- Huang, Q.; Fang, C.; Shi, J.; Sun, Q.; Wu, H.; Gold, J. S.; Weber, H. C.; Guan, W.; Zhang, Y.; Yu, C.; et al. Differences in Clinicopathology of Early Gastric Carcinoma between Proximal and Distal Location in 438 Chinese Patients. Sci. Rep. 2015, 5, 13439. DOI: https://doi.org/10.1038/srep13439.
- Smeets, M. F.; Chan, A. C.; Dagger, S.; Bradley, C. K.; Wei, A.; Izon, D. J. Fli-1 Overexpression in Hematopoietic Progenitors Deregulates T Cell Development and Induces pre-T Cell Lymphoblastic Leukaemia/lymphoma. PLoS One. 2013, 8, e62346. DOI: https://doi.org/10.1371/journal.pone.0062346.
- Pimanda, J. E.; Chan, W. Y.; Donaldson, I.; Bowen, M.; Green, A. R.; Göttgens, B. Endoglin Expression in the Endothelium Is Regulated by Fli-1, Erg, and Elf-1 Acting on the Promoter and a −8-kb Enhancer. Blood. 2006, 107, 4737–4745. DOI: https://doi.org/10.1182/blood-2005-12-4929.
- Asano, Y.; Bujor, A. M.; Trojanowska, M. The Impact of Fli-1 Deficiency on the Pathogenesis of Systemic Sclerosis. J. Dermatol. Sci. 2010, 59, 153–162. DOI: https://doi.org/10.1016/j.jdermsci.2010.06.008.
- Li, Y.; Luo, H.; Liu, T.; Zacksenhaus, E.; Ben-David, Y. The Ets Transcription Factor Fli-1 in Development, Cancer and Disease. Oncogene. 2015, 34, 2022–2031. DOI: https://doi.org/10.1038/onc.2014.162.
- Cui, J. W.; Vecchiarelli-Federico, L. M.; Li, Y. J.; Wang, G. J.; Ben-David, Y. Continuous Fli-1 Expression Plays an Essential Role in the Proliferation and Survival of F-MuLV-induced Erythroleukemia and Human Erythroleukemia. Leukemia. 2009, 23, 1311–1319. DOI: https://doi.org/10.1038/leu.2009.20.
- Truong, A. H.; Ben-David, Y. The Role of Fli-1 in Normal Cell Function and Malignant Transformation. Oncogene. 2000, 19, 6482–6489. DOI: https://doi.org/10.1038/sj.onc.1204042.
- Sepulveda, J. L.; Gutierrez-Pajares, J. L.; Luna, A.; Yao, Y.; Tobias, J. W.; Thomas, S.; Woo, Y.; Giorgi, F.; Komissarova, E. V.; Califano, A.; et al. High-definition CpG Methylation of Novel Genes in Gastric Carcinogenesis Identified by Next-generation Sequencing. Mod. Pathol. 2016, 29, 182–193. DOI: https://doi.org/10.1038/modpathol.2015.144.
- Del Portillo, A.; Komissarova, E. V.; Bokhari, A.; Hills, C.; De Gonzalez, A.; Koehne Kongkarnka, S.; Remotti, H. E.; Sepulveda, J. L.; Sepulveda, A. R. Downregulation of Friend Leukemia Integration 1 (FLI1) Follows the Stepwise Progression to Gastric Adenocarcinoma. Oncotarget. 2019, 10, 3852–3864. DOI: https://doi.org/10.18632/oncotarget.26974.
- Hanahan, D.; Weinberg, R. A. Hallmarks of Cancer: The Next Generation. Cell. 2011, 144(5), 646–674. DOI: https://doi.org/10.1016/j.cell.2011.02.013.
- Zhang, X.; Liu, X.; Zhou, D.; Zheng, G. Targeting Anti-apoptotic BCL-2 Family Proteins for Cancer Treatment. Future Med. Chem. 2020 Apr, 12(7), 563–565. Epub 2020 Feb 21. PMID: 32083493. DOI: https://doi.org/10.4155/fmc-2020-0004.
- Sakurai, T.; Kondoh, N.; Arai, M.; Hamada, J.; Yamada, T.; Kihara-Negishi, F.; Ohno, H.; Yamamoto, M.; Oikawa, T. Functional Roles of Fli-1, a Member of the Ets Family of Transcription Factors, in Human Breast Malignancy. Cancer Sci. 2007, 98, 1775–1784. [PubMed: 17727680]. DOI: https://doi.org/10.1111/j.1349-7006.2007.00598.x.
- Lesault, I.; Quang, C. T.; Frampton, J.; Ghysdael, J. Direct Regulation of BCL-2 by FLI-1 Is Involved in the Survival of FLI-1-transformed Erythroblasts. EMBO J. 2002, 21, 694–703. DOI: https://doi.org/10.1093/emboj/21.4.694.
- Lauwers, G.; Carneiro, F.; Graham, D. et al Gastric carcinoma. In: Bosman, F.; Carneiro, F.; Hruban, R.; Theise, N. eds. WHO Classification of Tumours of the Digestive System. 4th edition. Lyons, France; IARC Press; 2010: 48-58.
- Washington, K. 7th Edition of the AJCC Cancer Staging Manual: Stomach. Ann. Surg. Oncol. 2010, 17, 3077–3079. DOI: https://doi.org/10.1245/s10434-010-1362-z.
- Song, W.; Li, W.; Li, L.; Zhang, S.; Yan, X.; Wen, X.; Zhang, X.; Tian, H.; Li, A.; Hu, J. F.;, et al. Friend Leukemia Virus Integration 1 Activates the Rho GTPase Pathway and Is Associated with Metastasis in Breast Cancer. Oncotarget. 2015 Sep 15, 6(27), 23764–23775. DOI: https://doi.org/10.18632/oncotarget.4350.
- Koshida, Y.; Saegusa, M.; Okayasu, I. Apoptosis Cell Proliferation and Expression of Bcl-2 and Bax in Gastric Carcinomas: Immunohistochemical and Clinicopathological Study. Br. J. Cancer. 1997, 75, 367–373. DOI: https://doi.org/10.1038/bjc.1997.60.
- Seth, A.; Watson, D. K. ETS Transcription Factors and Their Emerging Roles in Human Cancer. Eur. J. Cancer. 2005, 41(16), 2462–2478. DOI: https://doi.org/10.1016/j.ejca.2005.08.013.
- Uren, A.; Toretsky, J. A. Ewing’s Sarcoma Oncoprotein EWS‐FLI1: The Perfect Target without a Therapeutic Agent. Future Oncol. 2005, 1, 521‐ 528. DOI: https://doi.org/10.2217/14796694.1.4.521.
- Scheiber, M. N.; Watson, P. M.; Rumboldt, T.; Stanley, C.; Wilson, R. C.; Findlay, V. J.; Anderson, P. E.; Watson, D. K. FLI1 Expression Is Correlated with Breast Cancer Cellular Growth, Migration, and Invasion and Altered Gene Expression. Neoplasia. Oct 23 2014, 16(10), 801–813. DOI: https://doi.org/10.1016/j.neo.2014.08.007.
- Zhang, J.; Guo, H.; Zhang, H. E.; Wang, H.; Qian, G.; Fan, X.; Hoffman, A. R.; Hu, J. F.; Ge, S. Putative Tumor Suppressor miR145 Inhibits Colon Cancer Cell Growth by Targeting Oncogene Friend Leukemia Virus Integration 1 Gene. Cancer. 2011, 117, 86–95. DOI: https://doi.org/10.1002/cncr.25522.
- Tsamandas, A. C.; Kardamakis, D.; Tsiamalos, P.; Liava, A.; Tzelepi, V.; Vassiliou, V.; Petsas, T.; Vagenas, K.; Zolota, V.; Scopa, C. D. The Potential Role of Bcl-2 Expression, Apoptosis and Cell Proliferation (Ki-67 Expression) in Cases of Gastric Carcinoma and Correlation with Classic Prognostic Factors and Patient Outcome. Anticancer Res. Feb 2009, 29(2): 703–709.
- Kopp, R.; Diebold, J.; Dreier, I.; Cramer, C.; Glas, J.; Baretton, G.; Jauch, K. W. Prognostic Relevance of P53 and Bcl-2 Immunoreactivity for Early Invasive pT1/pT2 Gastric Carcinomas. Surg. Endosc. 2005, 19, 1507–1512. DOI: https://doi.org/10.1007/s00464-005-0043-7.
- Müller, W.; Schneiders, A.; Hommel, G.; Gabbert, H. E. Prognostic Value of Bcl-2 Expression in Gastric Cancer. Anticancer Res. 1998, 18(6B), 4699–4704.
- Lauwers, G. Y.; Scott, G. V.; Karpeh, M. S. Immunohistochemical Evaluation of Bcl-2 Protein Expression in Gastric Adenocarcinomas. Cancer. May 1 1995, 75(9), 2209–2213. DOI: https://doi.org/10.1002/1097-0142(19950501)75:9<2209::AID-CNCR2820750904>3.0.CO;2-M.
- Song, W.; Hu, L.; Li, W.; Wang, G.; Li, Y.; Yan, L.; Li, A.; Cui, J. Oncogenic Fli-1 Is a Potential Prognostic Marker for the Progression of Epithelial Ovarian Cancer. BMC Cancer, 2014. DOI: https://doi.org/10.1186/1471-2407-14-424.
- Yi, H.; Fujimura, Y.; Ouchida, M.; Prasad, D. D.; Rao, V. N.; Reddy, E. S. Inhibition of Apoptosis by Normal and Aberrant Fli-1 and Erg Proteins Involved in Human Solid Tumors and Leukemias. Oncogene. 1997, 14, 1259‐ 1268. DOI: https://doi.org/10.1038/sj.onc.1201099.